Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Eli Lilly and Company (NYSE:LLY) Shares Up 1.5% | news.google.com • |
How To Trade (LLY) | news.google.com • |
Forget Nvidia, These Unstoppable Stocks Are Better Buys | news.google.com • |
Forget Nvidia, These Unstoppable Stocks Are Better Buys | fool.com • |
Mogy Joel R Investment Counsel Inc. Purchases 7,733 Shares of Eli Lilly and Company (NYSE:LLY) | news.google.com • |
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On | fool.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-30 | 2024-03 | 2.53 | N/A | N/A | N/A |
2024-02-06 | 2023-12 | 2.47 | 2.49 | 0.02 | 0.81% |
2023-11-02 | 2023-09 | -0.08 | 0.1 | 0.18 | 225.00% |
2023-08-08 | 2023-06 | 1.98 | 2.11 | 0.13 | 6.57% |
2023-04-27 | 2023-03 | 1.73 | 1.62 | -0.11 | -6.36% |
2023-02-02 | 2022-12 | 1.83 | 2.09 | 0.26 | 14.21% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-10-08 | Wells Fargo | Upgrade | Overweight | Overweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-01 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-04-14 | ALVAREZ RALPH | Director | 54.03K | Stock Award(Grant) |
2024-02-11 | HAKIM ANAT | General Counsel | 30.48K | Stock Award(Grant) |
2024-04-14 | HEDLEY MARY LYNNE | Director | 1.58K | Stock Award(Grant) |
2024-04-14 | JOHNSON KIMBERLY H | Director | 2.63K | Stock Award(Grant) |
2024-02-15 | LILLY ENDOWMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 98.90M | Sale |
2024-04-14 | LUCIANO JUAN R | Director | 15.68K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Lilly Endowment, Inc | 99.98M | 53.70B | 10.53% |
2023-06-29 | Vanguard Group Inc | 69.92M | 32.79B | 7.37% |
2023-06-29 | Blackrock Inc. | 64.45M | 30.23B | 6.79% |
2023-06-29 | PNC Financial Services Group, Inc. | 51.87M | 24.33B | 5.46% |
2023-06-29 | State Street Corporation | 33.88M | 15.89B | 3.57% |
2023-06-29 | FMR, LLC | 32.80M | 15.38B | 3.46% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 26.65M | 12.50B | 2.81% |
2023-06-29 | Vanguard 500 Index Fund | 18.76M | 8.80B | 1.98% |
2023-06-29 | Vanguard/Primecap Fund | 13.35M | 6.26B | 1.41% |
2023-05-30 | Fidelity 500 Index Fund | 8.83M | 3.79B | 0.93% |
2023-08-30 | SPDR S&P 500 ETF Trust | 8.68M | 4.81B | 0.91% |
2023-08-30 | iShares Core S&P 500 ETF | 7.37M | 4.08B | 0.78% |
Dividend | Date |
---|---|
1.3 | 2024-02-15 |
1.3 | 2024-02-14 |
1.13 | 2023-11-14 |
1.13 | 2023-09-08 |
1.13 | 2023-08-14 |
1.13 | 2023-05-12 |
Split | Date |
---|---|
2 : 1 | 1997-10-16 |
2 : 1 | 1995-12-21 |
2 : 1 | 1989-05-01 |
2 : 1 | 1986-01-30 |
-
How much of this is already baked into the stock price?
-
-
-
$LLY Total over reaction. Screaming buy. On sale!
-
-
$LLY Total gift at this price. Thx u
-
-
$LLY…buying here…Minimally shortened prospects only because of the US$ strength... very attractive pipeline and with the blockbuster approval of Mounjaro and another 4 planned new approvals within the next 18 months, I will buy every dip.
Greetings from Frankfurt/Germany -
Be careful $LLY can fall to $260 suddenly any next second!
-
Blockbuster Diabetes drug injectable Mounjaro just approved by FDA with significant weight loss. Also undergoing trials for obese people without diabetes with results comparable to gastric bypass. Been buying dip on Wed., Today and more on Friday. This is a breakout drug that will bring in billions of new profits.
-
-
-
Eli Lilly to enter licence agreement for novel CX3CR1 inhibitor, undertake responsibility for clinical development, commercialization?
-
Sorrento therapeutics
-
Less dose! 10times as potent ! Don’t need infusion
-
Sorrento is better
-
-
-
Eli Lilly and Company (NYSE:LLY) Shares Up 1.5%
news.google.com • -
How To Trade (LLY)
news.google.com • -
Forget Nvidia, These Unstoppable Stocks Are Better Buys
news.google.com • -
What You Need To Know Ahead of Eli Lilly's Earnings Report Tuesday
investopedia.com • -
Eli Lilly & Co. stock outperforms competitors on strong trading day
news.google.com • -
LLY June 7th Options Begin Trading
news.google.com • -
MSN
news.google.com • -
Analysts Set Eli Lilly and Company (NYSE:LLY) Target Price at $728.05
news.google.com • -
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.3%
news.google.com • -
Is Eli Lilly Stock A Buy After Weight-Loss Win In Sleep Apnea?
news.google.com • -
Don't Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List
investorplace.com • -
LLY vs. JNJ: Which Big Pharma Stock Is Better?- TipRanks
news.google.com • -
Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses
investorplace.com • -
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
news.google.com • -
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
news.google.com • -
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
news.google.com • -
Eli Lilly and Company (LLY) to Release Quarterly Earnings on Tuesday
news.google.com • -
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
news.google.com • -
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans- TipRanks
news.google.com • -
7 High-Flying Stocks That Are Majorly Overdue for a Pullback
investorplace.com • -
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S
news.google.com • -
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S
news.google.com • -
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
marketbeat.com • -
11 Hot Growth Stocks To Buy Right Now
news.google.com • -
Bearish on SMCI & Bullish on LLY, NFLX
youtube.com • -
Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now
investorplace.com • -
Big pharma: cautious optimism ahead of earnings season - analysts
proactiveinvestors.com • -
Eli Lilly's Chart Gets Another Boost from Obesity Drug
youtube.com • -
Eli Lilly's Weight-Loss Treatment Found To Help Those With Sleep Apnea
investopedia.com • -
Eli Lilly's weight-loss drug Zepbound might help cure your sleep apnea
fastcompany.com • -
Eli Lilly Stock Pops on Drug Efficacy for Sleep Apnea
schaeffersresearch.com • -
Eli Lilly's weightloss drug helps reduce sleep apnoea
proactiveinvestors.com • -
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
investorplace.com • -
3 Growth Stocks with Even Greater Potential Than the Magnificent 7
investorplace.com • -
Why Eli Lilly Stock Topped the Market Today
fool.com • -
The 3 Best Healthcare Stocks to Buy in April 2024
investorplace.com • -
Biotech's Next Gold Rush: Weight-Loss Drugs
youtube.com • -
5 Healthcare Stocks to Buy for 2024
investorplace.com • -
Is It Too Late to Buy Eli Lilly Stock?
fool.com • -
Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
seekingalpha.com •